{"id":50739,"date":"2022-11-10T23:02:21","date_gmt":"2022-11-10T22:02:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/"},"modified":"2022-11-10T23:02:21","modified_gmt":"2022-11-10T22:02:21","slug":"thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/","title":{"rendered":"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases"},"content":{"rendered":"
\n

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.\n<\/p>\n

<\/a><\/p>\n

\nAbout Thermo Fisher Scientific
\n
<\/b>Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact Information:
\n
Sandy Pound
\n
781-622-1223
\n
sandy.pound@thermofisher.com<\/a>\n<\/p>\n

\nInvestor Contact Information:
\n
Rafael Tejada
\n
781-622-1356
\n
rafael.tejada@thermofisher.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. About Thermo Fisher Scientific Thermo Fisher Scientific … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50739","6":"format-standard","7":"category-industry"},"yoast_head":"\nThermo Fisher Scientific Authorizes $4 Billion of Share Repurchases - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. About Thermo Fisher Scientific Thermo Fisher Scientific ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-10T22:02:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221110006109\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases\",\"datePublished\":\"2022-11-10T22:02:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/\"},\"wordCount\":194,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221110006109\\\/en\\\/1387941\\\/21\\\/Thermo_Fisher_Scientific.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/\",\"name\":\"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221110006109\\\/en\\\/1387941\\\/21\\\/Thermo_Fisher_Scientific.jpg\",\"datePublished\":\"2022-11-10T22:02:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221110006109\\\/en\\\/1387941\\\/21\\\/Thermo_Fisher_Scientific.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221110006109\\\/en\\\/1387941\\\/21\\\/Thermo_Fisher_Scientific.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/","og_locale":"en_US","og_type":"article","og_title":"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases - Pharma Trend","og_description":"WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. About Thermo Fisher Scientific Thermo Fisher Scientific ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-10T22:02:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221110006109\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases","datePublished":"2022-11-10T22:02:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/"},"wordCount":194,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221110006109\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/","url":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/","name":"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221110006109\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg","datePublished":"2022-11-10T22:02:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221110006109\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221110006109\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-authorizes-4-billion-of-share-repurchases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50739"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50739\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}